Table 1 Major differences in the scoring guidelines
Lesion Size | AASLD/LI-RADS | EASL | APASL | KLCA-NCC |
|---|---|---|---|---|
Any | > 1 cm | Any | > 1 cm | |
Criteria for diagnosis of HCC | LR-5 (i) Lesion size ≥ 20 mm APHE and one of the following: - Non-peripheral washout - Enhancing capsule - Threshold growth (ii) Lesion size 10–19 mm and 1 of the following - Non peripheral washout - threshold growth (iii) Lesion size 10–19 mm and 2 or more of the following - Non peripheral washout - Threshold growth - Enhancing capsule | APHE and Washout | APHE and washout | APHE and washout |
Phases accepted for washout | PVP or HVP (Extracellular agent) PVP only (EOB-MRI) | PVP only | PVP or HBP | PVP or TP or HBP |